相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Epidemiology and surveillance for hepatocellular carcinoma: New trends
Amit G. Singal et al.
JOURNAL OF HEPATOLOGY (2020)
Role of locoregional therapies in the wake of systemic therapy
Daniel H. Palmer et al.
JOURNAL OF HEPATOLOGY (2020)
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
Masatoshi Kudo et al.
GUT (2020)
Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial
Roser Pinyol et al.
GUT (2019)
Hepatobiliary Cancers, Version 2.2019 Featured Updates to the NCCN Guidelines
Al B. Benson et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Immune checkpoint inhibitors for hepatocellular carcinoma
Imane El Dika et al.
CANCER (2019)
Current State of Liver-Directed Therapies and Combinatory Approaches with Systemic Therapy in Hepatocellular Carcinoma (HCC)
Pedro Viveiros et al.
CANCERS (2019)
Baseline and Early Predictors of Good Patient Candidates for Second-Line after Sorafenib Treatment in Unresectable Hepatocellular Carcinoma
Hitomi Takada et al.
CANCERS (2019)
Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directions
Marc Hilmi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence
Jean-Luc Raoul et al.
CANCER TREATMENT REVIEWS (2019)
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Opportunities and Challenges
Xiufeng Liu et al.
ONCOLOGIST (2019)
Safety assessment of sorafenib in Chinese patients with unresectable hepatocellular carcinoma: subgroup analysis of the GIDEON study
Sheng-Long Ye et al.
BMC CANCER (2018)
Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study
Zheng Wang et al.
CLINICAL CANCER RESEARCH (2018)
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2018)
Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radlotrequency Ablation
Zhenwei Peng et al.
RADIOLOGY (2018)
Central hepatectomy versus major hepatectomy for patients with centrally located hepatocellular carcinoma: A meta-analysis
Yang Xiao et al.
INTERNATIONAL JOURNAL OF SURGERY (2018)
Identifying the Best Anticancer Agent Combination in TACE for HCC Patients: A Network Meta-analysis
Tao Guo et al.
JOURNAL OF CANCER (2018)
Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)
Jian Zhou et al.
LIVER CANCER (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Outcomes of patients (pts) with hepatocellular carcinoma (HCC) treated with transarterial chemoembolization (TACE): Global OPTIMIS final analysis.
Markus Peck-Radosavljevic et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Liver cancer incidence and mortality in China: Temporal trends and projections to 2030
Rongshou Zheng et al.
CHINESE JOURNAL OF CANCER RESEARCH (2018)
Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas
Guoying Zhou et al.
GASTROENTEROLOGY (2017)
The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2017)
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B. El-Khoueiry et al.
LANCET (2017)
Sorafenib: A Review in Hepatocellular Carcinoma
Gillian M. Keating
TARGETED ONCOLOGY (2017)
Efficacy and safety of TACE in combination with sorafenib for the treatment of TACE-refractory advanced hepatocellular carcinoma in Chinese patients: a retrospective study
Jianbing Wu et al.
ONCOTARGETS AND THERAPY (2017)
A phase Ib/II trial of lenvatinib (LEN) plus pembrolizumab (Pembro) in patients (Pts) with endometrial carcinoma.
Vicky Makker et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial
Tim Meyer et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery
Mingsheng Huang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial
Riccardo Lencioni et al.
JOURNAL OF HEPATOLOGY (2016)
Transarterial chemoembolization: Modalities, indication, and patient selection
Wolfgang Sieghart et al.
JOURNAL OF HEPATOLOGY (2015)
Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system
Kichang Han et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Surgical treatment of intra hepatic recurrence of hepatocellular carcinoma
Laurence Lacaze et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Recent advances in the surgical treatment of hepatocellular carcinoma
Zenichi Morise et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan
Masatoshi Kudo et al.
LIVER CANCER (2014)
Chemoembolization for Hepatocellular Carcinoma
Riccardo Lencioni
SEMINARS IN ONCOLOGY (2012)
Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version
Masatoshi Kudo et al.
DIGESTIVE DISEASES (2011)
Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): The role of angiogenesis and invasiveness
Adriana Sergio et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
分享论文
